Influence of the decarboxylase inhibitor benserazide on the antihypertensive effect and metabolism of alpha-methyldopa in patients with essential hypertension. 1977

G Planz, and H W Gierlichs, and A Hawlina, and R Planz, and W Stephany, and K H Rahn

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008750 Methyldopa An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent. Methyldopate,alpha-Methyldopa,Aldomet,Alphamethyldopa,Apo-Methyldopa,Dopamet,Dopegit,Dopegyt,Dopergit,Hydopa,Meldopa,Nu-Medopa,Sembrina,alpha-Methyl-L-Dopa,Apo Methyldopa,Nu Medopa,alpha Methyl L Dopa,alpha Methyldopa
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females

Related Publications

G Planz, and H W Gierlichs, and A Hawlina, and R Planz, and W Stephany, and K H Rahn
January 1988, AMB : revista da Associacao Medica Brasileira,
G Planz, and H W Gierlichs, and A Hawlina, and R Planz, and W Stephany, and K H Rahn
December 1963, Il Farmaco; edizione pratica,
G Planz, and H W Gierlichs, and A Hawlina, and R Planz, and W Stephany, and K H Rahn
January 1980, Arzneimittel-Forschung,
G Planz, and H W Gierlichs, and A Hawlina, and R Planz, and W Stephany, and K H Rahn
April 1991, Journal of clinical pharmacology,
G Planz, and H W Gierlichs, and A Hawlina, and R Planz, and W Stephany, and K H Rahn
January 1964, Archivos del Instituto de Cardiologia de Mexico,
G Planz, and H W Gierlichs, and A Hawlina, and R Planz, and W Stephany, and K H Rahn
January 1975, Naunyn-Schmiedeberg's archives of pharmacology,
G Planz, and H W Gierlichs, and A Hawlina, and R Planz, and W Stephany, and K H Rahn
August 1964, Nature,
G Planz, and H W Gierlichs, and A Hawlina, and R Planz, and W Stephany, and K H Rahn
January 1983, Indian heart journal,
G Planz, and H W Gierlichs, and A Hawlina, and R Planz, and W Stephany, and K H Rahn
May 1982, La Clinica terapeutica,
G Planz, and H W Gierlichs, and A Hawlina, and R Planz, and W Stephany, and K H Rahn
July 1983, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Copied contents to your clipboard!